Azur Pharma
Friday, 20 January 2012
Advised Azur Pharma on its merger with Nasdaq-listed Jazz Pharmaceuticals Inc. The new combined entity will trade as Jazz Pharmaceuticals plc, a dynamic specialty pharmaceutical company dedicated to improving patients' lives by identifying, developing, and commercializing innovative products that address unmet medical needs.
RELATED SERVICES
RELATED PEOPLE
RELATED LINKS
